News | National Commission on Correctional Health Care
As we work with more facilities seeking to treat patients with opioid use disorder, a specific challenge has emerged with injectable extended-release naltrexone (XR-NTX).
As our approach to COVID-19 takes a new turn with the introduction of vaccines, it’s time to prepare for educating staff and incarcerated people
by James W. Grigg, MD, Ross MacDonald, MD, and Rachael Bedard, MD. A significant amount of national attention has focused on the risks of coronavirus
Centurion Health has made a generous gift to the NCCHC Foundation in support of conference scholarships.
2021 welcome jpg e1609277319526
by Joseph V. Penn, MD, CCHP-MH As we bid farewell to 2020 and welcome 2021, I hope that you are feeling encouraged by the
coronavirus behind bars e1609262088119
Q: I am concerned about maintaining our facility’s accreditation status because, in response to COVID, we have made some changes in the way we
dollars g9becf4eb5 1920 squ100w
Correctional health care leaders can have a major impact on controlling health care costs in ways you may have never considered. Performing services in-house,
NCCHC position statement calls for reducing or stopping the use of restrictive housing for youths who are incarcerated and clear guidelines established for when
addiction week 2 e1634674745412
As the United States battles a growing opioid epidemic, corrections professionals face the considerable demands of managing a population increasingly dependent on opioids. Although
Catch up on Correctional Health Care Online November 17-18, 2021.
COVID-19 vaccines are safe and extremely effective against severe disease and death from COVID. And yet, the CDC reports that as of August 1,
Q: We are starting to use inmate workers at our jail. What do we need to do to ensure we are following NCCHC standards?